Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-28
2000-03-07
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514336, 514438, 514444, 544296, 544300, 5462804, 549 59, 549 78, 549 79, A61K 31505, A61K 3144, A61K 3138, C07D40300, C07D40900
Patent
active
060340894
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE IV). ##STR1## The invention also encompasses certain pharmaceutical compositions and methods for treatment of diseases by inhibition of PDE IV, resulting in an elevation of cAMP, comprising the use of compounds of Formula I.
REFERENCES:
patent: 3222290 (1965-12-01), Braus et al.
patent: 5474995 (1995-12-01), Durcharme et al.
Takeda et al, "Preparation of 2,5-diphenylpyrrole derivatives as anti-dermatitis drugs", CA126:89251, Feb. 14, 1997.
Porizet et al, "Thiophene S-Oxides . . . ", J. Chem. Soc. Chem. Commun., 1995.
Gotthardt, H. et al. Chem. Ber. 111: 2028-2036 (1978).
Burger, K. et al. Heterocycles 39(2): 819-832 (1994).
Minato, A. et al. Tet. Let. 21: 4017-4020 (1980).
Freeman, F. et al. J. Org. Chem. 59: 4350-4354 (1994).
Bottcher, V. B. et al. Justis Liebigs Annalen Der Chemie 557: 89-107 (1947) .
Giroux Andre
Han Yongxin
Lepine Carole
MacDonald Dwight
Perrier Helene
Lambkin Deborah C.
Lee Shu Muk
Merck & Co. , Inc.
Rose David L.
LandOfFree
Aryl thiophene derivatives as PDE IV inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl thiophene derivatives as PDE IV inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl thiophene derivatives as PDE IV inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363387